Search PubMedSearch

PubMed · 299835

Sudden death.

Abstract

The alert physician can identify and probably alter the risk of sudden death for certain patients (see Table 5). It appears preferable to study the patient who has already been identified as having coronary artery disease because of clinical symptoms such as R/O MI, which has been shown to have a high risk for subsequent sudden death. In addition, the physician must be sensitive to the middle-aged man with multiple coronary artery disease risk factors who suddenly decides to have a routine check or develops nonspecific complaints. Once identified, patients can be educated to minimize delay time in seeking medical help with crescendo or prolonged angina. Ambulatory ECG monitoring for detection and characterization of ventricular arrhythmias, and exercise stress testing to detect severe ST depression, can facilitate an estimation of the patient's prognosis. A therapeutic plan, including attack on the patient's coronary artery disease risk factors, patient education, and specific medical or surgical therapies may alter the risk of sudden death. Once an infarction has occurred, rapid transport to a coronary care unit or monitoring facility, and administration of intramuscular lidocaine by medical or paramedical personnel when feasible, appear to lessen out-of-hospital mortality.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J S Schroeder. 1977. Sudden death.. https://pubmed.ncbi.nlm.nih.gov/299835/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Comparison of painful and painless left ventricular dysfunction recorded during ambulatory ventricular function monitoring in angina pectoris secondary to coronary artery disease.

Left ventricular (LV) function and the electrocardiogram of 55 patients with coronary artery disease and angina were monitored for a mean of 3.2 +/- 1.9 hours with an ambulatory LV function monitor. During the monitoring interval, patients performed daily activities such as sitting, walking, climbing stairs, and eating. Sixty episodes of transient reduction in ejection fraction of > 5% lasting > 60 seconds were observed in 24 patients; 13 episodes were associated with typical angina, but 47 were asymptomatic. Asymptomatic episodes had a shorter duration of ventricular dysfunction (116 +/- 49 vs 189 +/- 113 seconds; p < 0.05), and smaller increases in relative end-diastolic and end-systolic volumes (end-diastolic 0.9 +/- 5.4% vs 4.6 +/- 4.9% [p < 0.05], and end-systolic 21 +/- 11% vs 35 +/- 20% [p < 0.05]) than did symptomatic ones. When a subset of patients with both symptomatic and asymptomatic episodes were analyzed, similar results were observed: in asymptomatic episodes, duration was shorter (82 +/- 31 vs 200 +/- 110 seconds; p < 0.005), ejection fraction decrease was smaller (-7.3 +/- 2.6% vs -11.0 +/- 4.7%; p < 0.05), and end-systolic volume increase was smaller (23 +/- 12% vs 37 +/- 19%; p < 0.05). The data suggest that asymptomatic transient LV dysfunction is less severe and of shorter duration in patients with angina pectoris.

Angina Pectoris

[Angina pectoris after sumatriptan (Imigran)].

Developed for the treatment of migraine, sumatriptan is an agonist of 5-hydroxytryptamine-1-receptors. Though a pressure sensation is a common complaint, significant ECG changes have not been reported after subcutaneous administration of sumatriptan. A case history is given where angina pectoris after sumatriptan self-administration was experienced on two occasions by a 61-year old man with a history of minor myocardial infarction--without post-infarction angina--two years previously. The angina after sumatriptan was accompanied on both occasions by significant ST-segment depression on ECG-monitoring. An extracranial vasoconstrictor action of sumatriptan in patients with ischaemic heart disease is suggested.

Angina Pectoris